Difference between revisions of "Part:BBa K3960017"

 
(13 intermediate revisions by 2 users not shown)
Line 19: Line 19:
 
We are SYSU-CHINA 2021.This year, we utilize circRNA as molecular scaffold to colalize enzymes, through the interaction of RNA aptamers and RNA binding proteins.
 
We are SYSU-CHINA 2021.This year, we utilize circRNA as molecular scaffold to colalize enzymes, through the interaction of RNA aptamers and RNA binding proteins.
 
===Design===
 
===Design===
Bfore constuction, we first use RNA Designer to generate a RNA sequence, which meets our demangd: containing MS2 aptamer and PP7 aptamer, and the distance between them is 10nt; except for the two aptamers, no stem loop structures should be formed, in other words, it should be more like a "round shape" circRNA after ligation.
+
We used RNA Designer to generate an RNA sequence which contains MS2 aptamer and PP7 aptamer. The distance between two aptamers is 10nt. Except for the two aptamers, no stemloop structures would form based on the prediction. In other words, it presents like a "round shape" circRNA after ligation.
 
The 2D structure was predicted by RNAfold as follows:
 
The 2D structure was predicted by RNAfold as follows:
|image [[Image:SYSU-CHINA circRNA-1.png | border | center | 400px]]
+
[[Image:SYSU-CHINA circRNA-1.png | border | center | 400px]]
 
<center><font size="1">Figure 1.2D structure of circRNA scaffold 2</font></center>
 
<center><font size="1">Figure 1.2D structure of circRNA scaffold 2</font></center>
 
The 3D structure was predicted by the service of Xiaolab:
 
The 3D structure was predicted by the service of Xiaolab:
|image [[Image:SYSU-CHINA circRNA-2.png  | border | center | 400px]]
+
[[Image:3D sructure of circRNA 2.png  | border | center | 400px]]
 
<center><font size="1">Figure 2.3D structure of circRNA scaffold 2</font></center>
 
<center><font size="1">Figure 2.3D structure of circRNA scaffold 2</font></center>
 +
 
===Construction===
 
===Construction===
We used Thermo Scientific TranscriptAid T7 High Yield Transcription Kit(K0411) and followed its instruction.
+
We used Thermo Scientific TranscriptAid T7 High Yield Transcription Kit (K0411) to carry out in vitro transcription.
First, we have Tsingke Biotechnology synthesized the DNA template which will be used for in vitro transcription. The primers are below:  
+
Firstly, we designed the primers for DNA template amplification through PCR, which are shown as follow:  
F:5’-TAATACGACTCACTATAGGGG-3’
+
  F:5’-TAATACGACTCACTATAGGGG-3’
R:5’-CAGGTCCGTTGGTTCGTT-3’
+
  R:5’-CAGGTCCGTTGGTTCGTT-3’
After PCR amplification, we subsequently perform in vitro transcription as follows:
+
After PCR amplification, we subsequently performed in vitro transcription and the protocol is shown as follows:
|image [[Image: T7_transcription_in_vitro.png| border | center | 400px]]
+
[[Image: T7 transcription in vitro.png| border | center | 400px]]
|image [[Image: Transcripts.png| border | center | 400px]]
+
[[Image: SYSU1.png| border | center | 400px]]
 
<center><font size="1">Figure 3.result of in vitro transcription</font></center>
 
<center><font size="1">Figure 3.result of in vitro transcription</font></center>
Result shows that we successfully obtain liner RNA.
+
The result showed that we obtained linear RNA successfully.
Next, we use T4 RNA Ligase I to cyclize transcript above. The kit we use is the NEB’s T4 RNA Ligase 1 (ssRNA Ligase)(M0204S). Protocol lists below:
+
Next, we used T4 RNA Ligase I to cyclize the linear RNA above. We used T4 RNA Ligase 1(ssRNA Ligase)(NEB M0204S) for ligation. Protocol is listed below:
|image [[Image: T4_RNA_ligation.png | border | center | 400px]]
+
[[Image: T4_RNA_ligation.png | border | center | 400px]]
|image [[Image: T4_RNA_ligation_result1.png | border | center | 400px]]
+
[[Image: SYSU2.png | border | center | 400px]]
 
<center><font size="1">Figure 4.result of ligation</font></center>
 
<center><font size="1">Figure 4.result of ligation</font></center>
This result indicates false cyclization of liner RNA transcript.The possible reason may be the 5'triphosphate of liner transcripts.We ordered RNA 5'Polyphosphatase to solve this problem, but it has a long delivery time. So we ordered 5'monophosphate modified RNA oligos,which is circRNA scaffold 2(BBa K3960017),and perform ligation again. This time we get our circcular RNA scaffold!
+
This result indicated the failure of cyclization since the RNA was almost degradated by RNase R. The possible reason may be the 5'-triphosphate of liner transcripts, which can't be recognized by T4 RNA ligase. RNA 5'-Polyphosphatase can be used to solve this problem. Due to the limit of time, we directly ordered 5'monophosphate modified RNA oligos from Tsingke.We performed ligation again and we finally got our circular RNA scaffold!
|image [[Image: Successful ligation.png | border | center | 400px]]
+
[[Image: SYSU3.png | border | center | 400px]]
 
<center><font size="1">Figure 5.successful ligation </font></center>
 
<center><font size="1">Figure 5.successful ligation </font></center>
The left lane is liner RNA and the right one is cyclization product.Cyclization product has a lower migrating rate than liner ones.
+
The liner RNA and its cyclization product are shown on the picture. Cyclization product has lower migrating rate than linear one. We used RNase R to test the stability of our circRNA against exo-RNase.
To test the stability of our circRNA scaffold against exo-RNase, we performed RNase R experience.However,our circular RNA is sensitive to RNase R, as it put on the instruction of RNase R:it can digest some circRNA which are not resistant to RNase R.
+
[[Image: SYSU4.png| border | center | 400px]]
|image [[Image: RNase R experiment.png| border | center | 400px]]
+
 
<center><font size="1">Figure 6.RNase R experiment </font></center>
 
<center><font size="1">Figure 6.RNase R experiment </font></center>
Lane 1 is liner RNA with RNase R,lane 2 is liner RNA without RNase R,lane 3 is circRNA with RNase R, lane 4 is circRNA without RNase R.After long enough digestion, still some cyclization product exists, indication the successful of our ligation.We will design a more resistant RNA scaffold to RNase R in the future.
+
The result indicates that our circRNA is resistant to exonuclease like RNase R, which is more stable than the linear RNA.
===Application in split EGFP===
+
 
For the proof of concept, we planed to perform split EGFP, which is an usual method to detect protein-protein interaction. If we can demonstrate that two EGFP fragments can be dragged to each other through the interaction between RNA aptamer and RNA binding proteins, which are linked to the fragments, then we can say that our concept can be proved. The mechanism lists below:
+
===Application of split EGFP===
<br>|image [[Image:Mechanism of split EGFP.png | border | center | 400px]]
+
As for the proof of our concept, we planed to perform split EGFP experiment, which is an commonly used method to detect protein-protein interaction. If the two EGFP fragments can be dragged to each other through the interaction between RNA aptamer and RNA binding proteins, our concept can be proved. The mechanism is listed below:
 +
<br> [[Image:Mechanism of split EGFP.png | border | center | 400px]]
 
<center><font size="1">Figure 2.mechanism of split EGFP</font></center>
 
<center><font size="1">Figure 2.mechanism of split EGFP</font></center>
EGFP splits into to part: EGFP-N and EGFP-C. EGFP-N is fused to MS2 while EGFP-C is fused to PP7, respectively. There is MS2 aptamer and PP7 aptamer on our circRNA scaffold, which have a 10nt length spacer. After the binding of two RBPs, their fused EGFP fragments can be dragged closer and form a complete EGFP. Then we can perform FCM(flow cytometry) to detect brightness.  
+
EGFP splits into to part: EGFP-N and EGFP-C. EGFP-N is fused with MS2 while EGFP-C is fused with PP7 respectively. There is MS2 aptamer and PP7 aptamer on our circRNA scaffold, which has a 10nt length interval. After the binding of two RBPs, the split EGFP fragments can be dragged closer and form a complete EGFP. Then we can perform FCM(flow cytometry) experiment to detect the brightness.  
Our experiment included four groups, which are positive control(only transfected with plasmid which can express EGFP), negative control(transfected with nothing), experimental group(transfected with plasmids that can express EGFP-N-MS2 and EGFP-C-PP7 and circRNA scaffold 2), false positive group(transfected with plasmids that can express EGFP-N-MS2 and EGFP-C-PP7 but no circRNA), respectively. The results are as follows:
+
Our FCM experiment included four groups. The positive control was transfected with plasmid which can express EGFP while the negative control was transfected with nothing. Experimental group 1 was transfected with plasmids that can express EGFP-N-MS2 and EGFP-C-PP7. The experimental group 2 was transfected with plasmids that can express EGFP-N-MS2 and EGFP-C-PP7 and the circRNA was also transfected into the cells. The results are shown as follows:
|image [[Image:FCS1.png | border | center | 400px]]
+
[[Image:Fcs1.png | border | center | 400px]]
 
<center><font size="1">Figure 3.positive control</font></center>
 
<center><font size="1">Figure 3.positive control</font></center>
|image [[Image:FCS_Negative_control.png | border | center | 400px]]
+
[[Image:Fcs2.png | border | center | 400px]]
 
<center><font size="1">Figure 4.negative control</font></center>
 
<center><font size="1">Figure 4.negative control</font></center>
|image [[Image:FCS3.png | border | center | 400px]]
+
[[Image:Fcs4.png | border | center | 400px]]
<center><font size="1">Figure 5.co-transfection with circRNA scaffold</font></center>
+
<center><font size="1">Figure 5.co-transfection without circRNA scaffold</font></center>
|image [[Image:FCS4.png | border | center | 400px]]
+
[[Image:Fcs3.png | border | center | 400px]]
<center><font size="1">Figure 6.co-transfection without circRNA scaffold</font></center>
+
<center><font size="1">Figure 6.co-transfection with circRNA scaffold</font></center>
Result shows that the brightness of group4 is between group1 and group2, which conforms to our design. Brightness of group3 is as low as group1, indicating that no false positive effect are interfering our result. All in all, this split EGFP proves that our circRNA scaffold do work.
+
The result shows that the percentage of fluorescent cells of experimental group 2 is 17.17%, which is much larger than negative control(0.52%) and experimental group 1(0.66%). This result indicates that the existence of circRNA can promote the interaction between the two fragements of EGFP, which successfully proves our concept.

Latest revision as of 11:47, 21 October 2021


circRNA scaffold 2

circRNA with MS2 binding site(BBa_K3960006) and PP7 binding site(BBa_K3960007), spacer between them is 10 nt

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


We are SYSU-CHINA 2021.This year, we utilize circRNA as molecular scaffold to colalize enzymes, through the interaction of RNA aptamers and RNA binding proteins.

Design

We used RNA Designer to generate an RNA sequence which contains MS2 aptamer and PP7 aptamer. The distance between two aptamers is 10nt. Except for the two aptamers, no stemloop structures would form based on the prediction. In other words, it presents like a "round shape" circRNA after ligation. The 2D structure was predicted by RNAfold as follows:

SYSU-CHINA circRNA-1.png
Figure 1.2D structure of circRNA scaffold 2

The 3D structure was predicted by the service of Xiaolab:

3D sructure of circRNA 2.png
Figure 2.3D structure of circRNA scaffold 2

Construction

We used Thermo Scientific TranscriptAid T7 High Yield Transcription Kit (K0411) to carry out in vitro transcription. Firstly, we designed the primers for DNA template amplification through PCR, which are shown as follow:

 F:5’-TAATACGACTCACTATAGGGG-3’
 R:5’-CAGGTCCGTTGGTTCGTT-3’

After PCR amplification, we subsequently performed in vitro transcription and the protocol is shown as follows:

T7 transcription in vitro.png
SYSU1.png
Figure 3.result of in vitro transcription

The result showed that we obtained linear RNA successfully. Next, we used T4 RNA Ligase I to cyclize the linear RNA above. We used T4 RNA Ligase 1(ssRNA Ligase)(NEB M0204S) for ligation. Protocol is listed below:

T4 RNA ligation.png
SYSU2.png
Figure 4.result of ligation

This result indicated the failure of cyclization since the RNA was almost degradated by RNase R. The possible reason may be the 5'-triphosphate of liner transcripts, which can't be recognized by T4 RNA ligase. RNA 5'-Polyphosphatase can be used to solve this problem. Due to the limit of time, we directly ordered 5'monophosphate modified RNA oligos from Tsingke.We performed ligation again and we finally got our circular RNA scaffold!

SYSU3.png
Figure 5.successful ligation

The liner RNA and its cyclization product are shown on the picture. Cyclization product has lower migrating rate than linear one. We used RNase R to test the stability of our circRNA against exo-RNase.

SYSU4.png
Figure 6.RNase R experiment

The result indicates that our circRNA is resistant to exonuclease like RNase R, which is more stable than the linear RNA.

Application of split EGFP

As for the proof of our concept, we planed to perform split EGFP experiment, which is an commonly used method to detect protein-protein interaction. If the two EGFP fragments can be dragged to each other through the interaction between RNA aptamer and RNA binding proteins, our concept can be proved. The mechanism is listed below:


Mechanism of split EGFP.png
Figure 2.mechanism of split EGFP

EGFP splits into to part: EGFP-N and EGFP-C. EGFP-N is fused with MS2 while EGFP-C is fused with PP7 respectively. There is MS2 aptamer and PP7 aptamer on our circRNA scaffold, which has a 10nt length interval. After the binding of two RBPs, the split EGFP fragments can be dragged closer and form a complete EGFP. Then we can perform FCM(flow cytometry) experiment to detect the brightness. Our FCM experiment included four groups. The positive control was transfected with plasmid which can express EGFP while the negative control was transfected with nothing. Experimental group 1 was transfected with plasmids that can express EGFP-N-MS2 and EGFP-C-PP7. The experimental group 2 was transfected with plasmids that can express EGFP-N-MS2 and EGFP-C-PP7 and the circRNA was also transfected into the cells. The results are shown as follows:

Fcs1.png
Figure 3.positive control
Fcs2.png
Figure 4.negative control
Fcs4.png
Figure 5.co-transfection without circRNA scaffold
Fcs3.png
Figure 6.co-transfection with circRNA scaffold

The result shows that the percentage of fluorescent cells of experimental group 2 is 17.17%, which is much larger than negative control(0.52%) and experimental group 1(0.66%). This result indicates that the existence of circRNA can promote the interaction between the two fragements of EGFP, which successfully proves our concept.